Abstract

Understanding the impact of guide RNA (gRNA) and genomic locus on CRISPR-Cas9 activity is crucial to design effective gene editing assays. However, it is challenging to profile Cas9 activity in the endogenous cellular environment. Here we leverage our TRIP technology to integrate ~ 1k barcoded reporter genes in the genomes of mouse embryonic stem cells. We target the integrated reporters (IRs) using RNA-guided Cas9 and characterize induced mutations by sequencing. We report that gRNA-sequence and IR locus explain most variation in mutation efficiency. Predominant insertions of a gRNA-specific nucleotide are consistent with template-dependent repair of staggered DNA ends with 1-bp 5′ overhangs. We confirm that such staggered ends are induced by Cas9 in mouse pre-B cells. To explain observed insertions, we propose a model generating primarily blunt and occasionally staggered DNA ends. Mutation patterns indicate that gRNA-sequence controls the fraction of staggered ends, which could be used to optimize Cas9-based insertion efficiency.

Designing effective genome engineering strategies requires an understanding of the impact that genomic locus has on CRISPR-Cas9 activity. Here the authors use TRIP integrations to profile editing outcomes genome-wide and observe that gRNA sequence influences the structure of the double strand break.

Details

Title
Multiplexed Cas9 targeting reveals genomic location effects and gRNA-based staggered breaks influencing mutation efficiency
Author
Gisler Santiago 1   VIAFID ORCID Logo  ; Gonçalves, Joana P 2   VIAFID ORCID Logo  ; Akhtar Waseem 1 ; de Jong Johann 3 ; Pindyurin, Alexey V 4   VIAFID ORCID Logo  ; Wessels Lodewyk F A 2 ; van Lohuizen Maarten 1 

 Oncode and The Netherlands Cancer Institute, Division of Molecular Genetics, Amsterdam, The Netherlands (GRID:grid.430814.a) 
 Delft University of Technology, Department of Intelligent Systems, Delft, The Netherlands (GRID:grid.5292.c) (ISNI:0000 0001 2097 4740); Oncode and The Netherlands Cancer Institute, Division of Molecular Carcinogenesis, Amsterdam, The Netherlands (GRID:grid.430814.a) 
 Oncode and The Netherlands Cancer Institute, Division of Molecular Carcinogenesis, Amsterdam, The Netherlands (GRID:grid.430814.a); UCB Biosciences GmbH, Data & Translational Sciences Group, Monheim am Rhein, Germany (GRID:grid.420204.0) (ISNI:0000 0004 0455 9792) 
 Siberian Branch of Russian Academy of Sciences, Institute of Molecular and Cellular Biology, Novosibirsk, Russia (GRID:grid.415877.8) (ISNI:0000 0001 2254 1834); Oncode and The Netherlands Cancer Institute, Division of Gene Regulation, Amsterdam, The Netherlands (GRID:grid.430814.a) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2205393550
Copyright
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.